C
CGON
CG Oncology, Inc.
60.44
+0.59+0.98%Opening12:16 10/19 EDT
OPEN/PREV CLOSE62.36/62.54
TODAY RANGE59.86-62.36
VOL1.06M
MARKET CAP5.47B
52 WEEK RANGE35.80-80.97
AVG VOL (3M)879.00K
% TURNOVER0.65%
TURNOVER--
P/E (TTM)-22.8937
% RANGE4.00%
EPS(TTM)-2.6955
P/E(FORWARD)-18.6077
P/B5.30
BVPS11.65
DIVIDEND--
P/S1,231.74
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.18B
SHARES OUTSTANDING88.64M
NEXT EARNINGS11/12-11/16
FREE FLOAT84.02M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
CG Oncology, Inc. (CGON) Initiated with a Buy at Guggenheim
Simply Wall St·1d ago
CG Oncology (CGON) CCO Hire Puts Its Launch Valuation Narrative To The Test
Simply Wall St·3d ago
How Investors May Respond To CG Oncology (CGON) Hiring A Commercial Chief
NASDAQ·4d ago
Notable Monday Option Activity: GE, CGON, BE
Simply Wall St·10/14 02:25
CG Oncology (CGON) Names New Commercial Chief As Valuation Turns Back To Cretostimogene
TipRanks·10/13 12:10
CG Oncology appoints Isabel Kalofonos as chief commercial officer
Seeking Alpha·10/05 15:59
These healthcare stocks stand out with A+ growth grades
NASDAQ·09/22 19:21
Notable Tuesday Option Activity: ASTS, ILPT, CGON
Seeking Alpha·09/22 18:17
SBIO: Big Pharma Needs What This Fund Owns
TipRanks·09/10 12:50
Analysts’ Top Healthcare Picks: CG Oncology, Inc. (CGON), Opus Genetics (IRD)
Simply Wall St·08/27 04:43
Regulatory Momentum Around Oncolytic Virus Therapy Could Be A Game Changer For CG Oncology (CGON)
TipRanks·08/20 11:35
UBS Keeps Their Buy Rating on CG Oncology, Inc. (CGON)
Simply Wall St·08/19 23:32
How Investors May Respond To CG Oncology (CGON) Revenue Growth Alongside a Widening Net Loss
Seeking Alpha·08/14 01:57
CG Oncology: Circling Back After Huge Rally
Same Industry
Name/Symbol
Change%
Price